AU2001291225A1 - Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients - Google Patents

Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients

Info

Publication number
AU2001291225A1
AU2001291225A1 AU2001291225A AU9122501A AU2001291225A1 AU 2001291225 A1 AU2001291225 A1 AU 2001291225A1 AU 2001291225 A AU2001291225 A AU 2001291225A AU 9122501 A AU9122501 A AU 9122501A AU 2001291225 A1 AU2001291225 A1 AU 2001291225A1
Authority
AU
Australia
Prior art keywords
hiv
analysis
infected patients
clinical care
coreceptor use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291225A
Other languages
English (en)
Inventor
Harold Burger
Cristina Kitchen
Sean Philpott
Barbara Weiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Research Inc
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of AU2001291225A1 publication Critical patent/AU2001291225A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001291225A 2000-09-26 2001-09-25 Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients Abandoned AU2001291225A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23567100P 2000-09-26 2000-09-26
US60/235,671 2000-09-26
US28235401P 2001-04-06 2001-04-06
US60/282,354 2001-04-06
PCT/US2001/029881 WO2002027321A2 (en) 2000-09-26 2001-09-25 Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients

Publications (1)

Publication Number Publication Date
AU2001291225A1 true AU2001291225A1 (en) 2002-04-08

Family

ID=26929120

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291225A Abandoned AU2001291225A1 (en) 2000-09-26 2001-09-25 Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients

Country Status (4)

Country Link
US (4) US6727060B2 (de)
EP (2) EP2333543B1 (de)
AU (1) AU2001291225A1 (de)
WO (1) WO2002027321A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344830B2 (en) * 2000-09-26 2008-03-18 Health Research Inc. Heteroduplex tracking assay
US7718356B2 (en) * 2000-09-26 2010-05-18 Health Research Inc. Heteroduplex tracking assay
US7203952B2 (en) * 2001-03-27 2007-04-10 Digeo, Inc. Passive program completion status indicator for an electronic program guide
FR2875410B1 (fr) * 2004-09-23 2012-11-16 Guerbet Sa Composes de diagnostique pour le ciblage de recpteur a chimiokines
US7248359B2 (en) * 2005-03-30 2007-07-24 Applera Corporation Combining multi-spectral light from spatially separated sources
WO2007084568A2 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
WO2007088201A1 (en) * 2006-02-03 2007-08-09 Virco Bvba Quantitative hiv phenotype or tropism assay
WO2008047227A2 (en) * 2006-10-20 2008-04-24 Eurofins Viralliance Inc. Method of assaying hiv-1 tropism for ccr5 and/or cxcr4 co-receptor and/or susceptibility to entry inhibitors
EP1914309A1 (de) * 2006-10-20 2008-04-23 Eurofins Viralliance Inc. Verfahren zur Ermittlung des HIV-1 Tropismus für CCR5 und/oder CXCR4 Co-Rezeptoren und/oder deren Empfindlichkeit gegenüber Eingangs-Inhibitoren
US20110230571A1 (en) 2007-10-26 2011-09-22 Alfred Health Diagnostic and therapeutic protocols
WO2009100284A2 (en) * 2008-02-06 2009-08-13 University Of Massachusetts Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects
US7888034B2 (en) * 2008-07-01 2011-02-15 454 Life Sciences Corporation System and method for detection of HIV tropism variants
EP2326957B1 (de) 2008-09-03 2013-06-12 Abbott Molecular Inc. Tests und kits zur bestimmung von hiv-1-tropismus
US8695420B1 (en) 2010-06-30 2014-04-15 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Liquid level sensing system

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5925525A (en) 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US5863542A (en) 1991-03-07 1999-01-26 Virogenetics Corporation Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts
US5766598A (en) 1991-03-07 1998-06-16 Virogenetics Corporation Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products
EP0916396B1 (de) 1991-11-22 2005-04-13 Affymetrix, Inc. (a Delaware Corporation) Kombinatorische Strategien für die Polymersynthese
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US6045996A (en) 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
EP0750680B1 (de) 1994-03-15 1999-01-13 Scientific Generics Ltd Elektrochemische denatusierung von doppelsträngiger nukleinsäure
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5710000A (en) 1994-09-16 1998-01-20 Affymetrix, Inc. Capturing sequences adjacent to Type-IIs restriction sites for genomic library mapping
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5639858A (en) 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
US5624711A (en) 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5968740A (en) 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
US5733729A (en) 1995-09-14 1998-03-31 Affymetrix, Inc. Computer-aided probability base calling for arrays of nucleic acid probes on chips
US5843655A (en) 1995-09-18 1998-12-01 Affymetrix, Inc. Methods for testing oligonucleotide arrays
US6022963A (en) 1995-12-15 2000-02-08 Affymetrix, Inc. Synthesis of oligonucleotide arrays using photocleavable protecting groups
US5837464A (en) * 1996-01-29 1998-11-17 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6013440A (en) 1996-03-11 2000-01-11 Affymetrix, Inc. Nucleic acid affinity columns
US6107019A (en) 1996-06-14 2000-08-22 Progenics Pharmaceuticals, Inc. Method for preventing HIV-1 infection of CD4+ cells
US5851759A (en) * 1996-04-19 1998-12-22 Chiron Corporation Heteroduplex tracking assay (HTA) for genotyping HCV
US5994515A (en) 1996-06-25 1999-11-30 Trustees Of The University Of Pennsylvania Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same
US6461809B1 (en) * 1996-10-15 2002-10-08 Bio-Tech Imaging, Inc Methods of improving infectivity of cells for viruses
US6004777A (en) 1997-03-12 1999-12-21 Virogenetics Corporation Vectors having enhanced expression, and methods of making and uses thereof
US5990091A (en) 1997-03-12 1999-11-23 Virogenetics Corporation Vectors having enhanced expression, and methods of making and uses thereof
US5843721A (en) 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
WO1999014378A2 (en) * 1997-09-19 1999-03-25 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods using interleukin 4 to treat hiv infection
DE69829402T2 (de) 1997-10-31 2006-04-13 Affymetrix, Inc. (a Delaware Corp.), Santa Clara Expressionsprofile in adulten und fötalen organen
CA2331760A1 (en) 1998-06-23 1999-12-29 John C. Kappes Cell-based assay for immunodeficiency virus infectivity and sensitivity
BR0110671A (pt) * 2000-04-27 2003-12-30 Consejo Superior Investigacion Método para detecção de genomas minoritários em quase-espécies virais e kit para detecção de genomas minoritários em quase-espécies virais
US20040067498A1 (en) * 2000-04-28 2004-04-08 Ahmed Chenna Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
US7718356B2 (en) * 2000-09-26 2010-05-18 Health Research Inc. Heteroduplex tracking assay
US20040110125A1 (en) * 2001-06-04 2004-06-10 Petropoulos Christos J. Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
US7247439B1 (en) * 2001-06-04 2007-07-24 Monogram Biosciences, Inc. Method of evaluating a patient antibody response to envelope proteins of a virus
US7097970B2 (en) * 2001-06-04 2006-08-29 Monogram Biosciences, Inc. Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs
WO2003083094A1 (en) 2002-03-29 2003-10-09 Innogenetics N.V. Hbv drug resistance drug resistance detection methods

Also Published As

Publication number Publication date
WO2002027321A9 (en) 2003-09-18
US20080227084A1 (en) 2008-09-18
EP1350100A2 (de) 2003-10-08
US7943297B2 (en) 2011-05-17
EP2333543B1 (de) 2018-01-10
US6727060B2 (en) 2004-04-27
US20090035749A2 (en) 2009-02-05
US20090117548A2 (en) 2009-05-07
US20040121318A1 (en) 2004-06-24
US7294458B2 (en) 2007-11-13
WO2002027321A2 (en) 2002-04-04
US20080096209A1 (en) 2008-04-24
US20020197734A1 (en) 2002-12-26
EP2333543A1 (de) 2011-06-15
WO2002027321A3 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU2002232104A1 (en) Syringe for use in blood analysis
AU2001291225A1 (en) Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients
DE50002860D1 (de) Spreizbares medizinisches instrument, insbesondere laryngoskop
HK1115537A1 (en) A use of hydroalcoholic gel in the manufacture of medicine
ATE216875T1 (de) Nichtinvasive impfung durch die haut
AU2001296550A1 (en) Dermabrasion and skin care apparatus
AU2001229778A1 (en) Health care payment and compliance system
MA26050A1 (fr) Infusion de liquides dans le corps humain ou animal
GB9904585D0 (en) Clinical and diagnostic database
DE602004031846D1 (de) Verbesserungen bei blutentnahmegeräten
AU2001246377A1 (en) Positioning aid for use in performing a tomographic functional examination of the cervical spine
EP1395823A4 (de) In blutanalysegeräten verwendeter einwegbecher und -konus
AU2001275492A1 (en) Illuminating dental/medical examination mirror
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
AU2002233357A1 (en) Determining the risk of caries in a patient
ATE258035T1 (de) Wegwerfartikel für menschliche fäkalien
FI20000818A0 (fi) Dermatologinen käyttö ja valmiste
ITMI20010737A0 (it) Adesivo per protesi dentarie e procedimenti per la sua preparazione
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
AU2001285683A1 (en) Mild enrichment of foetal cells from peripheral blood and use thereof
EP1458328A4 (de) Formulierungen zu verwendung in medizinischen oder diagnostischen verfahren
IL150623A0 (en) Measurement system for examining a section of tissue on a patient and the use of a measurement system of this type
AU2002220744A1 (en) T-cell epitope of the papillomavirus L1 and E7 protein and use thereof in diagnostics and therapy
AU2003223033A1 (en) System for point of care diagnosis and/or analysis
EP1424556A4 (de) Blutuntersuchungsgerät